Michal Kidacki is a Dermatology physician affiliated with University of Iowa. OpenAlex indexes 56 publications with 238 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Hawkins Dr
Iowa City, IA 522421009
Telephone
319-356-2856Provider last certified this registry record 16 Sept 2025.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Organon LLCProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
30.5%Corticosteroid30.5%Clobetasol Propionate53%Hydrocortisone47%Part D≥41 patientsDermatology
30.5%Corticosteroid19.4%Triamcinolone Acetonide100%Part D≥54 patientsInterleukin-4 Receptor alpha Antagonist11.1%Dupixent Pen100%Part D<11 patientsAnti-infectives
24.4%Azole Antifungal19.9%Ketoconazole100%Part D≥44 patientsTetracycline-class Drug4.5%Doxycycline Hyclate100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TIGIT agonism as a therapeutic strategy to suppress inflammation in hidradenitis suppurativa
Frontiers in Immunology
2026 - CEACAM5 as a biomarker of semi-solid, lepidic lung adenocarcinoma
Translational Lung Cancer Research
2026 - Misinformation is present in popular social media content about melanoma
Clinical and Experimental Dermatology
2026 - Differential expression of immune checkpoint VISTA in inflammatory skin diseases
Journal of Investigative Dermatology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Hunsicker, MD
University of Iowa
Brian Olshansky, MD
University of Iowa
Robert Weiss, MD
University of Iowa
Carla Nester, MD
University of Iowa
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”